Product Code: GMDHC5153IDB
Summary
Global Markets Direct's, 'Corticosteroid-Responsive Dermatoses - Pipeline Review, H1 2014', provides an overview of the Corticosteroid-Responsive Dermatoses's therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Corticosteroid-Responsive Dermatoses, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Corticosteroid-Responsive Dermatoses and special features on late-stage and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global therapeutic landscape of Corticosteroid-Responsive Dermatoses
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Corticosteroid-Responsive Dermatoses and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Corticosteroid-Responsive Dermatoses products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Corticosteroid-Responsive Dermatoses pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products
Reasons to buy
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Corticosteroid-Responsive Dermatoses
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Corticosteroid-Responsive Dermatoses pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents
- Table of Contents
- List of Tables
- List of Figures
- Introduction
- Global Markets Direct Report Coverage
- Corticosteroid-Responsive Dermatoses Overview
- Therapeutics Development
- Pipeline Products for Corticosteroid-Responsive Dermatoses - Overview
- Pipeline Products for Corticosteroid-Responsive Dermatoses - Comparative Analysis
- Corticosteroid-Responsive Dermatoses - Therapeutics under Development by Companies
- Corticosteroid-Responsive Dermatoses - Pipeline Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Corticosteroid-Responsive Dermatoses - Products under Development by Companies
- Corticosteroid-Responsive Dermatoses - Companies Involved in Therapeutics Development
- Echo Therapeutics, Inc.
- Nuvo Research Inc.
- Foamix Ltd.
- Corticosteroid-Responsive Dermatoses - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
- Drug Profiles
- triamcinolone hexacetonide - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- mometasone furoate - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- triamcinolone acetonide - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- betamethasone dipropionate - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- triamcinolone acetonide - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- clobetasol propionate - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- Corticosteroid-Responsive Dermatoses - Dormant Projects
- Corticosteroid-Responsive Dermatoses - Product Development Milestones
- Featured News & Press Releases
- Jun 11, 2012: Perrigo Announces Settlement Of Clobetasol Propionate E-foam Patent Litigation
- Aug 02, 2004: Salix Acquires Rights to Anusol-HC and Proctocort Products from King Pharmaceuticals
- Aug 03, 1988: Diprolene lotion, Schering-Plough's new topical steroid approved for marketing in United States.
- Jun 11, 1987: Diprolene AF Schering-Plough's new topical steroid, approved for marketing in United States.
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact Us
- Disclaimer
List of Tables
- Number of Products under Development for Corticosteroid-Responsive Dermatoses, H1 2014
- Number of Products under Development for Corticosteroid-Responsive Dermatoses - Comparative Analysis, H1 2014
- Number of Products under Development by Companies, H1 2014
- Comparative Analysis by Late Stage Development, H1 2014
- Comparative Analysis by Clinical Stage Development, H1 2014
- Comparative Analysis by Early Stage Development, H1 2014
- Products under Development by Companies, H1 2014
- Corticosteroid-Responsive Dermatoses - Pipeline by Echo Therapeutics, Inc., H1 2014
- Corticosteroid-Responsive Dermatoses - Pipeline by Nuvo Research Inc., H1 2014
- Corticosteroid-Responsive Dermatoses - Pipeline by Foamix Ltd., H1 2014
- Assessment by Monotherapy Products, H1 2014
- Number of Products by Stage and Target, H1 2014
- Number of Products by Stage and Mechanism of Action, H1 2014
- Number of Products by Stage and Route of Administration, H1 2014
- Number of Products by Stage and Molecule Type, H1 2014
- Corticosteroid-Responsive Dermatoses - Dormant Projects, H1 2014
List of Figures
- Number of Products under Development for Corticosteroid-Responsive Dermatoses, H1 2014
- Number of Products under Development for Corticosteroid-Responsive Dermatoses - Comparative Analysis, H1 2014
- Number of Products under Development by Companies, H1 2014
- Assessment by Monotherapy Products, H1 2014
- Number of Products by Stage and Top 10 Target, H1 2014
- Number of Products by Stage and Top 10 Mechanism of Action, H1 2014
- Number of Products by Top 10 Route of Administration, H1 2014
- Number of Products by Stage and Top 10 Route of Administration, H1 2014
- Number of Products by Stage and Top 10 Molecule Type, H1 2014
